Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 17, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2025. Go to the latest filing (Q3 2026)

37.7B USDQ4 2025
Total value of stock positions
37.7B USD
Positions
76
Share of the ten largest
34.7%

The ten largest positions Q4 2025

  1. Microsoft 4.1%▲ +32.4%
  2. PNC Financial Services 4.0%▼ −8.4%
  3. Taiwan Semiconductor Manufacturing (ADR) 4.0%▲ +24.6%
  4. Visa Inc. 3.7%▲ +37.5%
  5. Charles Schwab Corporation 3.7%▼ −16.3%
  6. Walt Disney Company (The) 3.4%▲ +7.1%
  7. Air Products 3.1%▲ +30.4%
  8. Mcdonalds Corp 2.9%▲ +7.2%
  9. Bridgebio Pharma Inc 2.9%▼ −9.9%
  10. Fortive 2.8%▼ −6.1%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2025

Positions Q4 2025 per 13F filing, 29 of 29
Symbol Weight Shares Reported value Change Held since
Bridgebio Pharma Inc 2.9% 14,393,934 1.1B USD −9.9% reduced Q2 2019 27 quarters
FTV Fortive 2.8% 19,228,265 1.1B USD −6.1% reduced Q3 2019 26 quarters
Api Group Corp 1.2% 11,537,518 441.4M USD −6.2% reduced Q2 2020 23 quarters
Biomarin Pharmaceutical Inc 1.0% 6,036,936 358.8M USD −27.5% reduced Q4 2021 17 quarters
Roivant Sciences Ltd 0.4% 6,443,191 139.8M USD −72.7% reduced Q4 2021 17 quarters
Trevi Therapeutics Inc 0.1% 3,198,644 40.0M USD −37.6% reduced Q3 2022 14 quarters
CSX CSX Corporation 1.3% 13,817,539 500.9M USD −13.4% reduced Q4 2022 13 quarters
Newamsterdam Pharma Company 0.4% 4,203,567 147.5M USD −35.1% reduced Q4 2022 13 quarters
HCA HCA Healthcare 1.2% 999,180 466.5M USD −27.6% reduced Q4 2023 9 quarters
Oric Pharmaceuticals Inc 0.1% 6,572,691 53.8M USD 0.0% reduced Q1 2024 8 quarters
JPM JPMorgan Chase 1.6% 1,905,982 614.1M USD −62.3% reduced Q2 2024 7 quarters
CVNA Carvana 1.2% 1,061,533 448.0M USD −49.5% reduced Q2 2024 7 quarters
Inhibrx Biosciences Inc 0.3% 1,437,705 113.6M USD −19.6% reduced Q2 2024 7 quarters
SCHW Charles Schwab Corporation 3.7% 13,872,905 1.4B USD −16.3% reduced Q3 2024 6 quarters
BAC Bank of America 0.7% 4,494,629 247.2M USD −60.9% reduced Q3 2024 6 quarters
BSX Boston Scientific 0.6% 2,509,808 239.3M USD −5.0% reduced Q3 2024 6 quarters
GM General Motors 1.5% 6,806,095 553.5M USD −47.8% reduced Q4 2024 5 quarters
COF Capital One 1.9% 2,952,317 715.5M USD −60.0% reduced Q1 2025 4 quarters
Amer Sports Inc 0.5% 4,814,290 179.8M USD −24.1% reduced Q1 2025 4 quarters
PNC PNC Financial Services 4.0% 7,287,068 1.5B USD −8.4% reduced Q2 2025 3 quarters
AMD Advanced Micro Devices 2.1% 3,742,191 801.4M USD −10.5% reduced Q2 2025 3 quarters
JCI Johnson Controls 1.9% 5,918,707 708.8M USD −12.9% reduced Q2 2025 3 quarters
UBS Group AG 1.1% 9,128,817 426.0M USD −30.3% reduced Q2 2025 3 quarters
Saia Inc 0.9% 1,088,582 355.4M USD −21.3% reduced Q2 2025 3 quarters
Ralliant Corp 0.4% 3,162,630 161.0M USD −37.8% reduced Q2 2025 3 quarters
CSGP CoStar Group 0.3% 1,442,582 97.0M USD −22.0% reduced Q2 2025 3 quarters
Masimo Corp 0.2% 514,340 66.9M USD −52.1% reduced Q2 2025 3 quarters
Celestica Inc 1.3% 1,699,236 502.3M USD −1.4% reduced Q3 2025 2 quarters
AON Aon plc 0.7% 783,650 276.5M USD −44.6% reduced Q3 2025 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 20.1%
  • Technology 10.6%
  • Consumer Discretionary 9.8%
  • Industrials 9.1%
  • Communication Services 7.6%
  • Materials 5.9%
  • Health Care 4.5%
  • Real Estate 3.7%
  • not in our coverage 28.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close